In Maryland, scientists have long known that breast cancer stem cells can survive chemotherapy, which is not good as those cells are usually in tumor centers and the ones you really want to get rid of because if they come back, the cancer is often fatal. Scientists found that proteins known as hypoxia-inducible factors (HIFs) are activated when exposed to chemotherapy and they then produce a protein called glutathione-S-transferase O1 (GSTO1) which turns on certain genes that help those nasty breast cancer stem cells survive. The gene expression analysis and experiments conducted in their lab showed that if they can block the HIFs, then the GSTO1 protein is never formed and the breast cancer stem cells couldn’t protect themselves against the chemotherapy, giving much hope for breast cancer patients.
Latest article
Yeast mode: Starbucks India offers fermented cold foam
In India, Starbucks is now offering a protein-packed cold foam made of biofermented yeast.
Developed by SuperYou, the foam adds 11-18 grams of protein...
Judge allows challenge to state’s cultivated meat ban to proceed
In Texas, a federal judge has refused to dismiss a lawsuit challenging the state’s ban on cultivated meat, allowing the case to proceed. Upside...
Bipartisan bill aims to boost biomanufacturing
In Nebraska, U.S. Senators Pete Ricketts (R) and Chris Coons (DE) have introduced the Renewable Chemicals Act, which would provide a targeted, short-term tax...